2024年3月期
決算短信補足資料
Supplement for the Consolidated Financial Statements for the Year Ended March 31, 2024
1. 宝ホールディングス(連結)
Takara Holdings Inc. ‐Consolidated‐
① グループ別要約損益計算書
Consolidated Statements of Income by Business Group (Summary)
② 要約貸借対照表
Consolidated Balance Sheets (Summary)
2. 宝酒造
Takara Shuzo
要約損益計算書
Statements of Income (Summary)
3. 宝酒造インターナショナルグループ
Takara Shuzo International Group
要約損益計算書
Statements of Income (Summary)
4. タカラバイオグループ
Takara Bio Group
要約損益計算書
Statements of Income (Summary)
5. 6年間の財務サマリー(グループ別)
Six-Year Financial Summary by Business Group
6. 2024年3月期 参考資料
Reference Data for the Year Ended March 31, 2024
7. 2025年3月期 業績予想
Financial forecast for the Year Ending March 31, 2025
① 宝ホールディングス(連結)
Takara Holdings Inc. ‐Consolidated‐
② 宝酒造
Takara Shuzo
③ 宝酒造インターナショナルグループ
Takara Shuzo International Group
④ タカラバイオグループ
Takara Bio Group
8. 2025年3月期 参考資料
Reference Data for the year ending March 31, 2025
広報・IR部 Public Relations&Investor Relations Dept.
TEL 075(241)5124
FAX 075(241)5127
E-Mail ir@takara.co.jp
将来見通しに関する注意事項
この資料中の当社および当社グループの現在の計画、見通し、戦略、確信などのうち、歴史的事実でないも のは、将来の業績に関する見通しであり、これらは現時点において入手可能な情報から得られた当社経営陣の 判断に基づくものですが、重大なリスクや不確実性を含んでいる情報から得られた多くの仮定および考えに基 づきなされたものであります。実際の業績は、さまざまな要素によりこれら予測とは大きく異なる結果となり得るこ とをご承知おきください。
実際の業績に影響を与える要素には、経済情勢、特に消費動向、為替レートの変動、法律・行政制度の変化、 競合会社の価格・製品戦略による圧力、当社の既存製品および新製品の販売力の低下、生産中断、当社の知 的所有権に対する侵害、急速な技術革新、重大な訴訟における不利な判決等がありますが、業績に影響を与 える要素はこれらに限定されるものではありません。
Forward-Looking Statements
Statements in this document, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to various factors.
Factors that could influence actual results include, but are not limited to, economic conditions, especially trends in consumer
spending, as well as exchange rate fluctuations, changes in laws and government systems, pressure from competitors' prices and product strategies, declines in selling power of the Company's existing and new products, disruptions to production, violations of the Company's intellectual property rights, rapid advances in technology and unfavorable verdicts in major litigation.
宝ホールディングス株式会社 広報・IR部
Takara Holdings Inc. Public Relations&Investor Relations Dept.
TEL 075(241)5124 FAX 075(241)5127
E-Mail ir@takara.co.jp
1. 宝ホールディングス(連結) :Takara Holdings Inc. ‐Consolidated‐
- グループ別要約損益計算書 :Consolidated Statements of Income by Business Group (Summary)
(百万円 :Millions of Yen) | |||||||||||||
2023年3月期 | 2024年3月期 | 対前期 | 対11/9予想 | ||||||||||
FY2023 | FY2024/Apr. 1, 2023 - Mar. 31, 2024 | Change from FY2023 | Change from forecast announced Nov. 2023 | ||||||||||
実績 | 11/9予想 | 実績 | 増減 | 率 | 増減 | 率 | |||||||
Actual | Forecast announced | Actual | Change | YOY% | Change | Change% | |||||||
(a) | Nov. 9, 2023 (b) | (c) | (c-a) | (c/a-1) | (c-b) | (c/b-1) | |||||||
宝酒造 | 122,921 | 122,467 | 123,786 | 864 | 0.7% | 1,319 | 1.1% | ||||||
Takara Shuzo | |||||||||||||
宝酒造インターナショナルグループ | 137,483 | 161,400 | 160,427 | 22,943 | 16.7% | △ 972 | △0.6% | ||||||
Takara Shuzo International Group | |||||||||||||
タカラバイオ グループ | 78,142 | 45,500 | 43,505 | △ 34,636 | △44.3% | △ 1,994 | △4.4% | ||||||
Takara Bio Group | |||||||||||||
その他 | 30,950 | 30,430 | 30,271 | △ 678 | △2.2% | △ 158 | △0.5% | ||||||
Other | |||||||||||||
調整額 | △ 18,832 | △ 18,797 | △ 18,619 | 213 | - | 177 | - | ||||||
Adjustment | |||||||||||||
売上高 | 350,665 | 341,000 | 339,372 | △ 11,293 | △3.2% | △ 1,627 | △0.5% | ||||||
Net sales | |||||||||||||
売上原価 | 230,723 | 226,600 | 225,438 | △ 5,285 | △2.3% | △ 1,161 | △0.5% | ||||||
Cost of sales | |||||||||||||
売上総利益 | 119,941 | 114,400 | 113,933 | △ 6,008 | △5.0% | △ 466 | △0.4% | ||||||
Gross profit | |||||||||||||
運送費、保管料 | 13,119 | 13,600 | 13,464 | 345 | 2.6% | △ 135 | △1.0% | ||||||
Transportation and storage | |||||||||||||
広告宣伝費 | 2,840 | 4,000 | 4,829 | 1,989 | 70.1% | 829 | 20.7% | ||||||
Advertising | |||||||||||||
販売促進費 | 4,220 | 5,000 | 4,315 | 95 | 2.3% | △ 684 | △13.7% | ||||||
Sales promotion | |||||||||||||
研究開発費 | 8,949 | 9,200 | 8,725 | △ 224 | △2.5% | △ 474 | △5.2% | ||||||
Research and development | |||||||||||||
管理費、その他 | 52,866 | 60,900 | 60,355 | 7,489 | 14.2% | △ 544 | △0.9% | ||||||
Other, net | |||||||||||||
販売費及び一般管理費 | 81,996 | 92,700 | 91,691 | 9,695 | 11.8% | △ 1,008 | △1.1% | ||||||
SG&A expenses | |||||||||||||
宝酒造 | 4,890 | 5,327 | 5,503 | 612 | 12.5% | 176 | 3.3% | ||||||
Takara Shuzo | |||||||||||||
宝酒造インターナショナルグループ | 10,821 | 12,200 | 12,291 | 1,470 | 13.6% | 91 | 0.8% | ||||||
Takara Shuzo International Group | |||||||||||||
タカラバイオ グループ | 20,541 | 3,000 | 3,003 | △ 17,537 | △85.4% | 3 | 0.1% | ||||||
Takara Bio Group | |||||||||||||
その他 | 2,293 | 2,371 | 2,363 | 69 | 3.0% | △ 7 | △0.3% | ||||||
Other | |||||||||||||
調整額 | △ 601 | △ 1,198 | △ 919 | △ 318 | - | 278 | - | ||||||
Adjustment | |||||||||||||
営業利益(△:損失) | 37,945 | 21,700 | 22,242 | △ 15,703 | △41.4% | 542 | 2.5% | ||||||
Operating income(Δ:loss) | |||||||||||||
受取利息・配当金 | 1,066 | 1,300 | 1,405 | 339 | 31.8% | 105 | 8.1% | ||||||
Interest and Dividends income | |||||||||||||
その他営業外収益 | 612 | 600 | 755 | 143 | 23.4% | 155 | 25.9% | ||||||
Other, net | |||||||||||||
営業外収益 | 1,678 | 1,900 | 2,161 | 482 | 28.8% | 261 | 13.7% | ||||||
Non-operating income | |||||||||||||
支払利息 | 324 | 450 | 450 | 125 | 38.8% | 0 | 0.2% | ||||||
Interest and discounts expenses | |||||||||||||
その他営業外費用 | 593 | 650 | 616 | 23 | 3.9% | △ 33 | △5.2% | ||||||
Other, net | |||||||||||||
営業外費用 | 917 | 1,100 | 1,066 | 149 | 16.2% | △ 33 | △3.0% | ||||||
Non-operating expenses | |||||||||||||
経常利益(△:損失) | 38,706 | 22,500 | 23,336 | △ 15,369 | △39.7% | 836 | 3.7% | ||||||
Ordinary income(Δ:loss) | |||||||||||||
特別利益 | 1,681 | 2,770 | 4,034 | 2,353 | 140.0% | 1,264 | 45.6% | ||||||
Extraordinary income | |||||||||||||
特別損失 | 694 | 670 | 1,132 | 437 | 62.9% | 462 | 69.0% | ||||||
Extraordinary loss | |||||||||||||
税金等調整前当期純利益(△:損失) | 39,692 | 24,600 | 26,238 | △ 13,453 | △33.9% | 1,638 | 6.7% | ||||||
Income before income taxes(Δ:loss) | |||||||||||||
法人税、住民税及び事業税 | 10,144 | 7,800 | 8,899 | △ 1,245 | △12.3% | 672 | 8.6% | ||||||
Current income taxes | |||||||||||||
法人税等調整額 | 857 | △ 426 | △ 1,283 | - | |||||||||
Deferred income taxes | |||||||||||||
当期純利益(△:損失) | 28,690 | 16,800 | 17,766 | △ 10,924 | △38.1% | 966 | 5.8% | ||||||
Net income(Δ:loss) | |||||||||||||
非支配株主に帰属する当期純利益(△:損失) | 7,483 | 1,800 | 1,589 | △ 5,893 | △78.8% | △ 210 | △11.7% | ||||||
Net income attributable to the noncontrolling interest(Δ:loss) | |||||||||||||
親会社株主に帰属する当期純利益(△:損失) | 21,206 | 15,000 | 16,176 | △ 5,030 | △23.7% | 1,176 | 7.8% | ||||||
Net income attributable to owners of the parent(Δ:loss) | |||||||||||||
設備投資額(有形・無形) | 14,165 | 24,307 | 21,915 | 7,749 | 54.7% | △ 2,392 | △9.8% | ||||||
Capital expenditures | |||||||||||||
減価償却費(有形・無形) | 9,118 | 10,100 | 9,999 | 880 | 9.7% | △ 100 | △1.0% | ||||||
Depreciation and Amortization | |||||||||||||
のれん償却額 | 998 | 1,300 | 1,179 | 181 | 18.1% | △ 120 | △9.3% | ||||||
Amortization of goodwill | |||||||||||||
営業外収益 | 受取利息 457、受取配当金 948 など | ||||||||||||
Non-operating income | Interest income 457, Dividends income 948 etc. | ||||||||||||
営業外費用 | 支払利息 405、不動産賃貸費用 105、製品等破損損失 44 など | ||||||||||||
Non-operating expenses | Interest expense 405, Real estate rental costs 105, Damage loss of products 44, etc. | ||||||||||||
特別利益 | 投資有価証券売却益 3,971 など (前期:受取保険金 678、投資有価証券売却益 674 | など) | |||||||||||
Extraordinary income | Gain on sale of investment securities 3,971 etc. (FY2023:Insurance claim income 678, Gain on sale of investment securities 674, etc.) | ||||||||||||
特別損失 | 固定資産除売却損 842、製品自主回収関連損失 82 など (前期: 固定資産除売却損 499 など) | ||||||||||||
Extraordinary loss | Loss on sales and retirement of non-current assets 842, Loss on product recall 82, etc. (FY2023: Loss on sales and retirement of non-current assets 499, etc.) | ||||||||||||
PAGE 1/15
Takara Holdings Inc. ‐Consolidated‐
② 要約貸借対照表 :Consolidated Balance Sheets (Summary) | |||||||
資産の部 :Assets | (百万円 :Millions of Yen) | ||||||
2023年3月期 | 2024年3月期 | 増減 | 主な増減理由 | ||||
3月期末 | 3月期末 | ||||||
As of Mar. 31, 2023 | As of Mar. 31, 2024 | Change | Reference | ||||
(流動資産) | 241,513 | 245,213 | 3,700 | ||||
(Total current assets) | |||||||
(億円 :One hundred millions of Yen) | |||||||
現金及び預金 | 96,820 | 95,085 | △ 1,734 | ||||
Cash and deposits | |||||||
受取手形及び売掛金 | 69,717 | 70,123 | 406 | ||||
Notes and accounts receivable-trade | |||||||
有価証券 | 459 | 22 | △ 436 | ||||
Marketable securities | |||||||
棚卸資産 | 66,904 | 71,052 | 4,148 | ||||
Inventories | |||||||
その他 | 8,305 | 9,745 | 1,440 | ||||
Other current assets | |||||||
貸倒引当金 | △ 694 | △ 817 | △ 123 | ||||
Allowance for doubtful accounts | |||||||
(固定資産) | 157,661 | 192,254 | 34,593 | ||||
(Total fixed assets) | |||||||
〔有形固定資産〕 | 88,890 | 104,882 | 15,991 | ||||
[Property, plant and equipment] | |||||||
建物及び構築物 | 36,778 | 38,298 | 1,520 | (当期の有形・無形固定資産の主な増減内訳) | |||
Buildings and structures | Reference of Property, plant and equipment and Intangible assets | ||||||
機械装置及び運搬具 | 15,265 | 16,019 | 753 | 新規取得 TS+41.0、TSI+66.2、TB+109.6 | |||
Machinery, equipment and vehicles | Newly purchases | ||||||
土地 | 20,861 | 21,665 | 804 | 減価償却 TS△25.8、TSI△26.1、TB△42.7 | |||
Land | Depreciation | ||||||
その他 | 15,985 | 28,898 | 12,913 | ||||
Other property, plant and equipment | |||||||
〔無形固定資産〕 | 15,931 | 18,336 | 2,404 | ||||
[Intangible fixed assets] | |||||||
のれん | 10,668 | 12,154 | 1,485 | ||||
Goodwill | |||||||
その他 | 5,262 | 6,181 | 918 | ||||
Other intangible fixed assets | |||||||
〔投資その他の資産〕 | 52,838 | 69,036 | 16,197 | ||||
[Investments and other assets] | |||||||
投資有価証券 | 30,573 | 43,597 | 13,023 | うち 時価評価 TH+126、売却 TH △8.77 | |||
Investment securities | Market valuation, Sale of investment securities | ||||||
その他 | 22,328 | 25,502 | 3,173 | ||||
Other assets | |||||||
貸倒引当金 | △ 64 | △ 62 | 1 | ||||
Allowance for doubtful accounts | |||||||
資産合計 | 399,174 | 437,468 | 38,293 | ||||
Total assets | |||||||
(TH=Takara Holdings Inc., TS=Takara Shuzo, TSI=Takara Shuzo International Group, TB=Takara Bio Group)
PAGE 2/15
Takara Holdings Inc. ‐Consolidated‐
② 要約貸借対照表 :Consolidated Balance Sheets (Summary) | |||||||
負債及び純資産 の部 :Liabilities and net assets | (百万円 :Millions of Yen) | ||||||
2023年3月期 | 2024年3月期 | 増減 | 主な増減理由 | ||||
3月期末 | 3月期末 | ||||||
As of Mar. 31, 2023 | As of Mar. 31, 2024 | Change | Reference | ||||
(流動負債) | 67,454 | 80,657 | 13,202 | ||||
(Total current liabilities) | |||||||
(億円 :One hundred millions of Yen) | |||||||
支払手形及び買掛金 | 21,775 | 22,315 | 539 | ||||
Notes and accounts payable-trade | |||||||
短期借入金 | 4,919 | 10,008 | 5,089 | TH +51.6 | |||
Short-term loans payable | |||||||
1年内償還予定の社債 | 0 | 5,000 | 5,000 | TH +50.0 (第15回普通社債 2024年4月償還) | |||
Current portion of bonds payable | (#15 SB Redemption Apr.2024) | ||||||
未払酒税 | 5,815 | 8,174 | 2,358 | ||||
Accrued alcohol tax | |||||||
未払費用 | 6,368 | 8,826 | 2,457 | ||||
Accrued expenses | |||||||
その他 | 28,576 | 26,333 | △ 2,243 | ||||
Other current liabilities | |||||||
(固定負債) | 76,401 | 76,345 | △ 55 | ||||
(Total non-current liabilities) | |||||||
社債 | 20,000 | 15,000 | △ 5,000 | TH △50.0 (第15回普通社債 2024年4月償還) | |||
Bonds payable | (#15 SB Redemption Apr.2024) | ||||||
長期借入金 | 15,186 | 10,422 | △ 4,763 | TH △51.0 | |||
Long-term loans payable | |||||||
退職給付に係る負債 | 8,925 | 8,735 | △ 190 | ||||
Net defined benefit liability | |||||||
預り金 | 5,087 | 5,081 | △ 6 | ||||
Deposits from customers | |||||||
その他 | 27,201 | 37,105 | 9,904 | ||||
Other non-current liabilities | |||||||
負債合計 | 143,856 | 157,003 | 13,146 | ||||
Total liabilities | |||||||
資本金 | 13,226 | 13,226 | 0 | ||||
Capital stock | |||||||
資本剰余金 | 1,994 | 2,716 | 722 | ||||
Capital surplus | |||||||
利益剰余金 | 163,825 | 169,909 | 6,084 | ||||
Retained earnings | |||||||
自己株式 | △ 1,682 | △ 2,103 | △ 420 | ||||
Treasury stock | |||||||
(株主資本) | 177,363 | 183,749 | 6,386 | ||||
(Total owner's equity) | |||||||
その他有価証券評価差額金 | 12,974 | 22,511 | 9,537 | TH +87.0 | |||
Valuation difference on available-for-sale securities | |||||||
繰延ヘッジ損益 | 286 | 3 | △ 283 | ||||
Deffered gains or losses on hedges | |||||||
為替換算調整勘定 | 13,686 | 22,389 | 8,702 | TSI +69.5、TB +17.4 | |||
Translation adjustments | |||||||
退職給付に係る調整累計額 | △ 359 | 12 | 371 | ||||
Remeasurements of defined benefit plans | |||||||
(その他の包括利益累計額) | 26,588 | 44,915 | 18,327 | ||||
(Total valuation and translation adjustments) | |||||||
(非支配株主持分) | 51,366 | 51,799 | 432 | ||||
(Noncontrolling interests) | |||||||
純資産合計 | 255,318 | 280,465 | 25,146 | ||||
Total net assets | |||||||
負債純資産合計 | 399,174 | 437,468 | 38,293 | ||||
Total liabilities and net assets | |||||||
(TH=Takara Holdings Inc., TS=Takara Shuzo, TSI=Takara Shuzo International Group, TB=Takara Bio Group)
PAGE 3/15
Takara Holdings Inc. ‐Consolidated‐
2. 宝酒造 :Takara Shuzo
要約損益計算書 :Statements of Income (Summary)
(百万円 :Millions of Yen)
2023年3月期 | 2024年3月期 | 対前期 | 対11/9予想 | |||||||
FY2023 | FY2024/Apr. 1, 2023 - Mar. 31, 2024 | Change from FY2023 | Change from forecast announced Nov. 2023 | |||||||
実績 | 11/9予想 | 実績 | 増減 | 率 | 増減 | 率 | ||||
Actual | Forecast announced | Actual | Change | YOY% | Change | Change% | ||||
(a) | Nov. 9, 2023 (b) | (c) | (c-a) | (c/a-1) | (c-b) | (c/b-1) | ||||
焼酎 | 36,597 | 33,655 | 34,324 | △ 2,272 | △ 6.2% | 669 | 2.0% | |||
Shochu | ||||||||||
清酒 | 12,145 | 11,358 | 11,548 | △ 596 | △ 4.9% | 190 | 1.7% | |||
Sake | ||||||||||
ソフトアルコール飲料 | 40,069 | 42,401 | 42,290 | 2,221 | 5.5% | △ 110 | △ 0.3% | |||
Light-alcohol refreshers | ||||||||||
その他酒類 | 5,328 | 5,410 | 5,434 | 105 | 2.0% | 24 | 0.4% | |||
Other liquors | ||||||||||
本みりん | 9,477 | 9,110 | 9,562 | 84 | 0.9% | 452 | 5.0% | |||
Hon Mirin | ||||||||||
その他調味料 | 8,780 | 9,186 | 9,223 | 442 | 5.0% | 37 | 0.4% | |||
Other seasonings | ||||||||||
原料用アルコール等 | 10,522 | 11,344 | 11,402 | 880 | 8.4% | 58 | 0.5% | |||
Raw alcohol | ||||||||||
売上高 | 122,921 | 122,467 | 123,786 | 864 | 0.7% | 1,319 | 1.1% | |||
Net sales | ||||||||||
売上原価 | 93,645 | 91,201 | 92,057 | △ 1,588 | △ 1.7% | 856 | 0.9% | |||
Cost of sales | ||||||||||
売上総利益 | 29,276 | 31,266 | 31,728 | 2,452 | 8.4% | 462 | 1.5% | |||
Gross profit | ||||||||||
運送費、保管料 | 7,857 | 7,879 | 7,791 | △ 65 | △ 0.8% | △ 87 | △ 1.1% | |||
Transportation and storage | ||||||||||
広告宣伝費 | 2,626 | 3,589 | 4,390 | 1,764 | 67.2% | 801 | 22.3% | |||
Advertising | ||||||||||
販売促進費 | 2,457 | 2,930 | 2,508 | 50 | 2.1% | △ 421 | △ 14.4% | |||
Sales promotion | ||||||||||
研究開発費 | 367 | 390 | 391 | 23 | 6.4% | 1 | 0.3% | |||
Research and development | ||||||||||
管理費、その他 | 11,076 | 11,151 | 11,143 | 67 | 0.6% | △ 7 | △ 0.1% | |||
Other, net | ||||||||||
販売費及び一般管理費 | 24,385 | 25,939 | 26,225 | 1,839 | 7.5% | 286 | 1.1% | |||
SG&A expenses | ||||||||||
営業利益(△:損失) | 4,890 | 5,327 | 5,503 | 612 | 12.5% | 176 | 3.3% | |||
Operating income(Δ:loss) | ||||||||||
営業外収益 | 544 | 354 | 388 | △ 156 | △ 28.7% | 34 | 9.8% | |||
Non-operating income | ||||||||||
営業外費用 | 567 | 247 | 256 | △ 311 | △ 54.9% | 9 | 3.7% | |||
Non-operating expenses | ||||||||||
経常利益(△:損失) | 4,867 | 5,434 | 5,635 | 768 | 15.8% | 201 | 3.7% | |||
Ordinary income(Δ:loss) | ||||||||||
特別利益 | 63 | 19 | 23 | △ 39 | △ 63.3% | 4 | 22.0% | |||
Extraordinary gain | ||||||||||
特別損失 | 234 | 552 | 510 | 275 | 117.3% | △ 41 | △ 7.5% | |||
Extraordinary loss | ||||||||||
税金等調整前当期純利益(△:損失) | 4,696 | 4,901 | 5,148 | 452 | 9.6% | 247 | 5.1% | |||
Income before income taxes(Δ:loss) | ||||||||||
法人税、住民税及び事業税 | 1,277 | 1,522 | 1,582 | 305 | 23.9% | 71 | 4.7% | |||
Current income taxes | ||||||||||
法人税等調整額 | 181 | 11 | △ 170 | △ 93.9% | ||||||
Deferred income taxes | ||||||||||
当期純利益(△:損失) | 3,237 | 3,379 | 3,554 | 317 | 9.8% | 175 | 5.2% | |||
Net income(Δ:loss) | ||||||||||
設備投資額(有形・無形) | 2,763 | 4,774 | 4,108 | 1,344 | 48.6% | △ 666 | △ 14.0% | |||
Capital expenditures | ||||||||||
減価償却費(有形・無形) | 2,467 | 2,604 | 2,586 | 118 | 4.8% | △ 17 | △ 0.7% | |||
Depreciation and Amortization | ||||||||||
PAGE 4/15
Takara Shuzo
3. 宝酒造インターナショナルグループ :Takara Shuzo International Group
要約損益計算書 :Statements of Income (Summary)
(百万円 :Millions of Yen)
2023年3月期 | 2024年3月期 | 対前期 | 対11/9予想 | ||||||||
FY2023 | FY2024/Apr. 1, 2023 - Mar. 31, 2024 | Change from FY2023 | Change from forecast announced Nov. 2023 | ||||||||
実績 | 11/9予想 | 実績 | 増減 | 率 | 増減 | 率 | |||||
Actual | Forecast announced | Actual | Change | YOY% | Change | Change% | |||||
(a) | Nov. 9, 2023 (b) | (c) | (c-a) | (c/a-1) | (c-b) | (c/b-1) | |||||
海外酒類事業 | 18,253 | 21,161 | 20,926 | 2,673 | 14.6% | △ 234 | △ 1.1% | ||||
Overseas Alcoholic beverages business | |||||||||||
海外日本食材卸事業 | 121,354 | 142,730 | 141,816 | 20,461 | 16.9% | △ 913 | △ 0.6% | ||||
Japanese food wholesale business in overseas markets | |||||||||||
その他 | 2,847 | 247 | 249 | △ 2,598 | △ 91.3% | 2 | 0.8% | ||||
Other | |||||||||||
連結消去 | △ | 4,972 | △ 2,740 | △ 2,564 | 2,407 | - | 175 | - | |||
Elimination | |||||||||||
売上高 | 137,483 | 161,400 | 160,427 | 22,943 | 16.7% | △ 972 | △ 0.6% | ||||
Net sales | |||||||||||
売上原価 | 95,088 | 109,940 | 108,711 | 13,623 | 14.3% | △ 1,228 | △ 1.1% | ||||
Cost of sales | |||||||||||
売上総利益 | 42,394 | 51,460 | 51,715 | 9,320 | 22.0% | 255 | 0.5% | ||||
Gross profit | |||||||||||
運送費、保管料 | 4,883 | 5,448 | 5,361 | 478 | 9.8% | △ 86 | △ 1.6% | ||||
Transportation and storage | |||||||||||
広告宣伝費 | 136 | 152 | 143 | 6 | 5.1% | △ 8 | △ 5.7% | ||||
Advertising | |||||||||||
販売促進費 | 1,109 | 1,326 | 1,169 | 59 | 5.4% | △ 156 | △ 11.8% | ||||
Sales promotion | |||||||||||
管理費、その他 | 25,443 | 32,334 | 32,748 | 7,305 | 28.7% | 414 | 1.3% | ||||
Other, net | |||||||||||
販売費及び一般管理費 | 31,573 | 39,260 | 39,423 | 7,850 | 24.9% | 163 | 0.4% | ||||
SG&A expenses | |||||||||||
海外酒類事業 | 4,895 | 5,861 | 5,755 | 859 | 17.6% | △ 105 | △ 1.8% | ||||
Overseas Alcoholic beverages business | |||||||||||
海外日本食材卸事業 | 7,559 | 8,764 | 8,883 | 1,324 | 17.5% | 119 | 1.4% | ||||
Japanese food wholesale business in overseas markets | |||||||||||
その他 | 1,700 | △ 1,186 | △ 1,149 | △ 2,849 | - | 36 | - | ||||
Other | |||||||||||
連結消去 | △ | 3,334 | △ 1,239 | △ 1,197 | 2,136 | - | 41 | - | |||
Elimination | |||||||||||
営業利益(△:損失) | 10,821 | 12,200 | 12,291 | 1,470 | 13.6% | 91 | 0.8% | ||||
Operating income(Δ:loss) | |||||||||||
営業外収益 | 315 | 436 | 483 | 167 | 53.0% | 47 | 10.8% | ||||
Non-operating income | |||||||||||
営業外費用 | 169 | 575 | 715 | 546 | 321.9% | 140 | 24.5% | ||||
Non-operating expenses | |||||||||||
経常利益(△:損失) | 10,967 | 12,061 | 12,059 | 1,091 | 10.0% | △ 1 | △ 0.0% | ||||
Ordinary income(Δ:loss) | |||||||||||
特別利益 | 8 | 25 | 42 | 33 | 398.1% | 17 | 69.4% | ||||
Extraordinary gain | |||||||||||
特別損失 | 68 | 50 | 65 | △ 2 | △ 3.9% | 15 | 31.5% | ||||
Extraordinary loss | |||||||||||
税金等調整前当期純利益(△:損失) | 10,907 | 12,036 | 12,036 | 1,128 | 10.3% | 0 | 0.0% | ||||
Income before income taxes(Δ:loss) | |||||||||||
法人税、住民税及び事業税 | 3,255 | 3,618 | 4,012 | 757 | 23.3% | △ 15 | △ 0.4% | ||||
Current income taxes | |||||||||||
法人税等調整額 | 28 | △ 410 | △ 439 | - | |||||||
Deferred income taxes | |||||||||||
当期純利益(△:損失) | 7,623 | 8,418 | 8,434 | 810 | 10.6% | 16 | 0.2% | ||||
Net income(Δ:loss) | |||||||||||
非支配株主に帰属する当期純利益(△:損失) | 1,189 | 1,021 | 982 | △ 206 | △ 17.4% | △ 38 | △ 3.8% | ||||
Net income attributable to the noncontrolling interest(Δ:loss) | |||||||||||
親会社株主に帰属する当期純利益(△:損失) | 6,434 | 7,397 | 7,451 | 1,017 | 15.8% | 54 | 0.7% | ||||
Net income attributable to owners of the parent(Δ:loss) | |||||||||||
設備投資額(有形・無形) | 4,704 | 3,187 | 6,624 | 1,919 | 40.8% | 3,437 | 107.8% | ||||
Capital expenditures | |||||||||||
減価償却費(有形・無形) | 2,043 | 2,439 | 2,618 | 575 | 28.2% | 179 | 7.4% | ||||
Depreciation and Amortization | |||||||||||
のれん償却額 | 399 | 701 | 539 | 140 | 35.1% | △ 161 | △ 23.1% | ||||
Amortization of goodwill | |||||||||||
PAGE 5/15
Takara Shuzo International Group
4. タカラバイオグループ :Takara Bio Group
要約損益計算書 :Statements of Income (Summary)
(百万円 :Millions of Yen)
2023年3月期 | 2024年3月期 | 対前期 | 対11/9予想 | |||||||
FY2023 | FY2024/Apr. 1, 2023 - Mar. 31, 2024 | Change from FY2023 | Change from forecast announced Nov. 2023 | |||||||
実績 | 11/9予想 | 実績 | 増減 | 率 | 増減 | 率 | ||||
Actual | Forecast announced | Actual | Change | YOY% | Change | Change% | ||||
(a) | Nov. 9, 2023 (b) | (c) | (c-a) | (c/a-1) | (c-b) | (c/b-1) | ||||
試薬 | 65,925 | 32,792 | 31,961 | △ 33,963 | △ 51.5% | △ 830 | △ 2.5% | |||
Reagents | ||||||||||
機器 | 1,375 | 1,314 | 892 | △ 482 | △ 35.1% | △ 421 | △ 32.0% | |||
Instruments | ||||||||||
受託 | 8,200 | 8,652 | 7,997 | △ 202 | △ 2.5% | △ 654 | △ 7.6% | |||
CDMO | ||||||||||
遺伝子医療 | 2,640 | 2,740 | 2,653 | 12 | 0.5% | △ 87 | △ 3.2% | |||
Gene Therapy | ||||||||||
売上高 | 78,142 | 45,500 | 43,505 | △ 34,636 | △ 44.3% | △ 1,994 | △ 4.4% | |||
Net sales | ||||||||||
売上原価 | 33,377 | 17,399 | 16,597 | △ 16,779 | △ 50.3% | △ 801 | △ 4.6% | |||
Cost of sales | ||||||||||
売上総利益 | 44,765 | 28,100 | 26,908 | △ 17,856 | △ 39.9% | △ 1,191 | △ 4.2% | |||
Gross profit | ||||||||||
運送費、保管料 | 653 | 638 | 571 | △ 81 | △ 12.4% | △ 66 | △ 10.3% | |||
Transportation and storage | ||||||||||
広告宣伝費 | 48 | 70 | 72 | 24 | 49.9% | 2 | 4.0% | |||
Advertising | ||||||||||
販売促進費 | 699 | 796 | 676 | △ 23 | △ 3.3% | △ 119 | △ 15.0% | |||
Sales promotion | ||||||||||
研究開発費 | 8,575 | 8,810 | 8,324 | △ 251 | △ 2.9% | △ 485 | △ 5.5% | |||
Research and development | ||||||||||
管理費、その他 | 14,247 | 14,785 | 14,259 | 12 | 0.1% | △ 525 | △ 3.6% | |||
Other, net | ||||||||||
販売費及び一般管理費 | 24,224 | 25,100 | 23,905 | △ 318 | △ 1.3% | △ 1,194 | △ 4.8% | |||
SG&A expenses | ||||||||||
営業利益(△:損失) | 20,541 | 3,000 | 3,003 | △ 17,537 | △ 85.4% | 3 | 0.1% | |||
Operating income(Δ:loss) | ||||||||||
営業外収益 | 363 | 394 | 513 | 150 | 41.5% | 119 | 30.4% | |||
Non-operating income | ||||||||||
営業外費用 | 221 | 194 | 111 | △ 110 | △ 49.7% | △ 82 | △ 42.5% | |||
Non-operating expenses | ||||||||||
経常利益(△:損失) | 20,682 | 3,200 | 3,405 | △ 17,277 | △ 83.5% | 205 | 6.4% | |||
Ordinary income(Δ:loss) | ||||||||||
特別利益 | 930 | 1 | 3 | △ 927 | △ 99.6% | 2 | 235.5% | |||
Extraordinary income | ||||||||||
特別損失 | 388 | 60 | 554 | 165 | 42.7% | 494 | 824.9% | |||
Extraordinary loss | ||||||||||
税金等調整前当期純利益(△:損失) | 21,224 | 3,140 | 2,853 | △ 18,370 | △ 86.6% | △ 286 | △ 9.1% | |||
Income before income taxes(Δ:loss) | ||||||||||
法人税、住民税及び事業税 | 4,679 | 1,110 | 1,292 | △ 3,386 | △ 72.4% | 233 | 21.0% | |||
Current income taxes | ||||||||||
法人税等調整額 | 496 | 50 | △ 446 | △ 89.8% | ||||||
Deferred income taxes | ||||||||||
当期純利益(△:損失) | 16,047 | 2,030 | 1,510 | △ 14,537 | △ 90.6% | △ 519 | △ 25.6% | |||
Net income(Δ:loss) | ||||||||||
非支配株主に帰属する当期純利益(△:損失) | 35 | 30 | 29 | △ 6 | △ 18.1% | △ 0 | △ 2.3% | |||
Net income attributable to the noncontrolling interest(Δ:loss) | ||||||||||
親会社株主に帰属する当期純利益(△:損失) | 16,012 | 2,000 | 1,480 | △ 14,531 | △ 90.8% | △ 519 | △ 26.0% | |||
Net income attributable to owners of the parent(Δ:loss) | ||||||||||
設備投資額(有形・無形) | 6,516 | 16,024 | 10,960 | 4,443 | 68.2% | △ 5,064 | △ 31.6% | |||
Capital expenditures | ||||||||||
減価償却費(有形・無形) | 4,050 | 4,552 | 4,279 | 229 | 5.7% | △ 272 | △ 6.0% | |||
Depreciation and Amortization | ||||||||||
のれん償却額 | 599 | 635 | 640 | 41 | 6.9% | 5 | 0.8% | |||
Amortization of goodwill | ||||||||||
PAGE 6/15
Takara Bio Group
5. 6年間の財務サマリー(グループ別) :Six-Year Financial Summary by Business Group
宝ホールディングス(連結) :Takara Holdings Inc. -Consolidated- | (百万円 :Millions of Yen) | ||||||||||||
2019年 | 2020年 | 2021年 | 2022年 | 2023年 | 2024年 | 前期対比 | |||||||
3月期 | 3月期 | 3月期 | 3月期 | 3月期 | 3月期 | Change from FY2023 | |||||||
FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | 増減 | 率 | ||||||
Change | YOY% | ||||||||||||
売上高 | Net sales | 277,443 | 281,191 | 278,443 | 300,918 | 350,665 | 339,372 | △ 11,293 | △ 3.2% | ||||
売上原価 | Cost of sales | 168,694 | 172,574 | 162,849 | 187,376 | 230,723 | 225,438 | △ 5,285 | △ 2.3% | ||||
(売上高原価率) | (Ratio to Net sales) | 60.8% | 61.4% | 58.5% | 62.3% | 65.8% | 66.4% | +0.6pt | 1.0% | ||||
売上総利益 | Gross profit | 108,749 | 108,617 | 115,594 | 113,541 | 119,941 | 113,933 | △ 6,008 | △ 5.0% | ||||
販売費及び一般管理費 | SG&A expenses | 90,945 | 92,781 | 93,999 | 70,187 | 81,996 | 91,691 | 9,695 | 11.8% | ||||
(売上高販管費率) | (Ratio to Net sales) | 32.8% | 33.0% | 33.8% | 23.3% | 23.4% | 27.0% | +3.6pt | 15.5% | ||||
営業利益(△:損失) | Operating income(Δ:loss) | 17,804 | 15,836 | 21,595 | 43,354 | 37,945 | 22,242 | △ 15,703 | △ 41.4% | ||||
(売上高営業利益率) | (Ratio to Net Sales) | 6.4% | 5.6% | 7.8% | 14.4% | 10.8% | 6.6% | △4.3pt | △ 39.4% | ||||
販売促進費、販売促進引当金繰入 Sales promotion and allowance for s.p. | 34,012 | 35,073 | 34,128 | 3,883 | 4,220 | 4,315 | 95 | 2.3% | |||||
(売上高販促費率) | (Ratio to Net sales) | 12.3% | 12.5% | 12.3% | 1.3% | 1.2% | 1.3% | +0.1pt | 5.7% | ||||
研究開発費 | R&D expenses | 4,708 | 4,259 | 5,914 | 6,484 | 8,949 | 8,725 | △ 224 | △ 2.5% | ||||
(売上高研究開発費率) | (Ratio to Net sales) | 1.7% | 1.5% | 2.1% | 2.2% | 2.6% | 2.6% | +0.0pt | 0.7% | ||||
設備投資額(有形・無形) | Capital expenditures | 10,671 | 14,195 | 13,775 | 16,213 | 14,165 | 21,915 | 7,749 | 54.7% | ||||
減価償却費(有形・無形) | Depreciation and Amortization | 6,490 | 7,626 | 8,068 | 8,425 | 9,118 | 9,999 | 880 | 9.7% | ||||
のれん償却額 | Amortization of goodwill | 865 | 847 | 865 | 875 | 998 | 1,179 | 181 | 18.1% | ||||
※2022年3月期より、収益認識に関する会計基準等の適用に伴い、従来販売費 及び一般管理費で処理していた費用の一部を売上高から控除しております。 | |||||||||||||
宝酒造 :Takara Shuzo | (百万円 :Millions of Yen) | ||||||||||||
2019年 | 2020年 | 2021年 | 2022年 | 2023年 | 2024年 | 前期対比 | |||||||
3月期 | 3月期 | 3月期 | 3月期 | 3月期 | 3月期 | Change from FY2023 | |||||||
FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | 増減 | 率 | ||||||
Change | YOY% | ||||||||||||
売上高 | Net sales | 152,457 | 153,141 | 152,537 | 119,710 | 122,921 | 123,786 | 864 | 0.7% | ||||
売上原価 | Cost of sales | 91,441 | 92,822 | 92,439 | 90,898 | 93,645 | 92,057 | △ 1,588 | △ 1.7% | ||||
(売上高原価率) | (Ratio to Net sales) | 60.0% | 60.6% | 60.6% | 75.9% | 76.2% | 74.4% | △1.8pt | △ 2.4% | ||||
売上総利益 | Gross profit | 61,015 | 60,318 | 60,098 | 28,811 | 29,276 | 31,728 | 2,452 | 8.4% | ||||
販売費及び一般管理費 | SG&A expenses | 55,067 | 56,142 | 55,218 | 24,676 | 24,385 | 26,225 | 1,839 | 7.5% | ||||
(売上高販管費率) | (Ratio to Net sales) | 36.1% | 36.7% | 36.2% | 20.6% | 19.8% | 21.2% | +1.3pt | 6.8% | ||||
営業利益(△:損失) | Operating income(Δ:loss) | 5,948 | 4,175 | 4,879 | 4,135 | 4,890 | 5,503 | 612 | 12.5% | ||||
(売上高営業利益率) | (Ratio to Net sales) | 3.9% | 2.7% | 3.2% | 3.5% | 4.0% | 4.4% | +0.5pt | 11.7% | ||||
販売促進費、販売促進引当金繰入 Sales promotion and allowance for s.p. | 32,658 | 33,844 | 32,981 | 2,423 | 2,457 | 2,508 | 50 | 2.1% | |||||
(売上高販促費率) | (Ratio to Net sales) | 21.4% | 22.1% | 21.6% | 2.0% | 2.0% | 2.0% | +0.0pt | 1.4% | ||||
設備投資額(有形・無形) | Capital expenditures | 3,128 | 5,520 | 1,430 | 1,785 | 2,763 | 4,108 | 1,344 | 48.6% | ||||
減価償却費(有形・無形) | Depreciation and Amortization | 2,248 | 2,736 | 2,848 | 2,590 | 2,467 | 2,586 | 118 | 4.8% | ||||
※2022年3月期より、収益認識に関する会計基準等の適用に伴い、従来販売費 及び一般管理費で処理していた費用の一部を売上高から控除しております。 | |||||||||||||
宝酒造インターナショナルグループ :Takara Shuzo International Group | (百万円 :Millions of Yen) | ||||||||||||
2019年 | 2020年 | 2021年 | 2022年 | 2023年 | 2024年 | 前期対比 | |||||||
3月期 | 3月期 | 3月期 | 3月期 | 3月期 | 3月期 | Change from FY2023 | |||||||
FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | 増減 | 率 | ||||||
Change | YOY% | ||||||||||||
売上高 | Net sales | 77,834 | 82,765 | 69,589 | 102,186 | 137,483 | 160,427 | 22,943 | 16.7% | ||||
売上原価 | Cost of sales | 54,823 | 58,882 | 48,983 | 70,045 | 95,088 | 108,711 | 13,623 | 14.3% | ||||
(売上高原価率) | (Ratio to Net sales) | 70.4% | 71.1% | 70.4% | 68.5% | 69.2% | 67.8% | △1.4pt | △ 2.0% | ||||
売上総利益 | Gross profit | 23,010 | 23,883 | 20,605 | 32,140 | 42,394 | 51,715 | 9,320 | 22.0% | ||||
販売費及び一般管理費 | SG&A expenses | 18,478 | 20,351 | 19,562 | 23,667 | 31,573 | 39,423 | 7,850 | 24.9% | ||||
(売上高販管費率) | (Ratio to Net sales) | 23.7% | 24.6% | 28.1% | 23.2% | 23.0% | 24.6% | +1.6pt | 7.0% | ||||
営業利益(△:損失) | Operating income(Δ:loss) | 4,532 | 3,532 | 1,043 | 8,472 | 10,821 | 12,291 | 1,470 | 13.6% | ||||
(売上高営業利益率) | (Ratio to Net sales) | 5.8% | 4.3% | 1.5% | 8.3% | 7.9% | 7.7% | △0.2pt | △ 2.7% | ||||
設備投資額(有形・無形) | Capital expenditures | 1,162 | 2,696 | 2,802 | 844 | 4,704 | 6,624 | 1,919 | 40.8% | ||||
減価償却費(有形・無形) | Depreciation and Amortization | 1,013 | 1,434 | 1,430 | 1,675 | 2,043 | 2,618 | 575 | 28.2% | ||||
のれん償却額 | Amortization of goodwill | 362 | 350 | 379 | 374 | 399 | 539 | 140 | 35.1% | ||||
タカラバイオグループ :Takara Bio Group | (百万円 :Millions of Yen) | ||||||||||||
2019年 | 2020年 | 2021年 | 2022年 | 2023年 | 2024年 | 前期対比 | |||||||
3月期 | 3月期 | 3月期 | 3月期 | 3月期 | 3月期 | Change from FY2023 | |||||||
FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | 増減 | 率 | ||||||
Change | YOY% | ||||||||||||
売上高 | Net sales | 35,841 | 34,565 | 46,086 | 67,699 | 78,142 | 43,505 | △ 34,636 | △ 44.3% | ||||
売上原価 | Cost of sales | 15,155 | 13,459 | 14,214 | 18,488 | 33,377 | 16,597 | △ 16,779 | △ 50.3% | ||||
(売上高原価率) | (Ratio to Net sales) | 42.3% | 38.9% | 30.8% | 27.3% | 42.7% | 38.1% | △4.6pt | △ 10.7% | ||||
売上総利益 | Gross profit | 20,685 | 21,105 | 31,872 | 49,211 | 44,765 | 26,908 | △ 17,856 | △ 39.9% | ||||
販売費及び一般管理費 | SG&A expenses | 15,221 | 14,830 | 17,919 | 20,309 | 24,224 | 23,905 | △ 318 | △ 1.3% | ||||
(売上高販管費率) | (Ratio to Net sales) | 42.5% | 42.9% | 38.9% | 30.0% | 31.0% | 54.9% | +23.9pt | 77.2% | ||||
営業利益(△:損失) | Operating income(Δ:loss) | 5,463 | 6,274 | 13,952 | 28,902 | 20,541 | 3,003 | △ 17,537 | △ 85.4% | ||||
(売上高営業利益率) | (Ratio to Net sales) | 15.2% | 18.2% | 30.3% | 42.7% | 26.3% | 6.9% | △19.4pt | △ 73.7% | ||||
研究開発費 | R&D expenses | 4,337 | 3,869 | 5,545 | 6,109 | 8,575 | 8,324 | △ 251 | △ 2.9% | ||||
(売上高研究開発費率) | (Ratio to Net sales) | 12.1% | 11.2% | 12.0% | 9.0% | 11.0% | 19.1% | +8.2pt | 74.3% | ||||
設備投資額(有形・無形) | Capital expenditures | 6,002 | 5,365 | 8,897 | 13,180 | 6,516 | 10,960 | 4,443 | 68.2% | ||||
減価償却費(有形・無形) | Depreciation and Amortization | 2,691 | 2,921 | 3,220 | 3,554 | 4,050 | 4,279 | 229 | 5.7% | ||||
のれん償却額 | Amortization of goodwill | 502 | 496 | 486 | 500 | 599 | 640 | 41 | 6.9% | ||||
PAGE 7/15
Six-Year Financial Summary by Business Group
6. 2024年3月期 参考資料 :Reference Data for the Year Ended March 31, 2024
① 為替前提及び売上高に対する為替レート変動の影響 :Exchange rates and effect of change in exchange rates on net sales
◆為替前提(海外子会社P/L換算用) :Exchange rates for the income statement of oversea subsidiaries (円 : Yen)
2023年3月期 | ||
FY2023 | ||
実績 | ||
Actual | ||
(a) | ||
米ドル : | US dollar | 131.64 |
ポンド: | Pound | 162.02 |
ユーロ: | Euro | 138.15 |
人民元: | Yuan | 19.50 |
100ウォン: 100 Won | 10.18 | |
インドルピー: Rupee | 1.67 | |
オーストラリアドル :Australian dollar | 91.13 | |
2024年3月期
FY2024/Apr. 1, 2023 - Mar. 31, 2024
実績
Actual | 前期差 |
- Change(b-a)
140.669.02
175.0313.01
- 13.95
- 0.32
10.770.59
1.700.03
93.352.22
◆売上高に対する為替レート変動の影響額 :Effect of change in exchange rates on net sales
(百万円 :Millions of Yen)
対前期
Change from FY2023
宝ホールディングス 計 | 12,662 | ||||
Net sales of Takara Holdings Inc. -Consolidated- | |||||
宝酒造インターナショナルグループ 計 | 11,123 | ||||
Net sales of Takara Shuzo International Group | |||||
海外酒類事業 | 1,311 | ||||
Overseas Alcoholic beverages business | |||||
海外日本食材卸事業 | 9,974 | ||||
Japanese food wholesale business in overseas markets | |||||
その他および調整額 | △ 162 | ||||
Other / Adjustment | |||||
タカラバイオグループ 計 | 1,539 | ||||
Net sales of Takara Bio Group | |||||
試薬 | 1,332 | ||||
Reagents | |||||
機器 | 24 | ||||
Instruments | |||||
受託 | 10 | ||||
CDMO | |||||
遺伝子医療 | 171 | ||||
Gene Therapy | |||||
② 海外売上高比率の推移 :Change in overseas sales ratio | |||||
(百万円 :Millions of Yen ) |
2023年3月期 実績 | |||||
FY2023 Actual | |||||
売上高計 | 海外売上高 | 海外売上高比率 | |||
Net Sales | Overseas Sales | Overseas Sales Ratio | |||
宝酒造 | 122,921 | 0 | - | ||
Takara Shuzo | |||||
宝酒造インターナショナルグループ | 137,483 | 136,900 | 99.6% | ||
Takara Shuzo International Group | |||||
タカラバイオグループ | 78,142 | 32,475 | 41.6% | ||
Takara Bio Group | |||||
その他および調整額 | 12,117 | 0 | - | ||
Other / Adjustment | |||||
宝ホールディングス(連結) | 350,665 | 169,375 | 48.3% | ||
Takara Holdings Inc. -Consolidated- | |||||
2024年3月期 実績
FY2024 Actual
売上高計 | 海外売上高 | 海外売上高比率 |
Net Sales | Overseas Sales | Overseas Sales Ratio |
123,786 | 0 | - |
160,427 | 159,642 | 99.5% |
43,505 | 28,071 | 64.5% |
11,652 | 0 | - |
339,372 | 187,714 | 55.3% |
PAGE 8/15
Reference Data
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Takara Holdings Inc. published this content on 05 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 June 2024 06:18:05 UTC.